(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $92.30
発行日: 14 2月 2024 @ 23:40
リターン: 11.80%
前回のシグナル: 2月 13 - 23:30
前回のシグナル:
リターン: 0.53 %
Live Chart Being Loaded With Signals
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally...
Stats | |
---|---|
本日の出来高 | 18 627.00 |
平均出来高 | 43 153.00 |
時価総額 | 556.61M |
EPS | $0 ( 2024-02-05 ) |
次の収益日 | ( $2.33 ) 2024-05-24 |
Last Dividend | $0.160 ( 2023-11-29 ) |
Next Dividend | $0 ( N/A ) |
P/E | 607.00 |
ATR14 | $0.497 (0.48%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-02 | Sullivan John James | Sell | 450 | Non Qualified Stock Option |
2024-04-02 | Sakys John | Sell | 2 500 | Non Qualified Stock Option |
2024-04-02 | Owens Gary M | Sell | 5 000 | Non Qualified Stock Options |
2024-04-02 | Archbold Brian David | Sell | 420 | Non Qualified Stock Option |
2024-01-08 | Archbold Brian David | Sell | 290 | Non Qualified Stock Option |
INSIDER POWER |
---|
12.66 |
Last 100 transactions |
Buy: 73 301 | Sell: 52 584 |
ボリューム 相関
Mesa Laboratories Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Mesa Laboratories Inc 相関 - 通貨/商品
Mesa Laboratories Inc 財務諸表
Annual | 2023 |
収益: | $219.08M |
総利益: | $133.69M (61.02 %) |
EPS: | $0.170 |
FY | 2023 |
収益: | $219.08M |
総利益: | $133.69M (61.02 %) |
EPS: | $0.170 |
FY | 2022 |
収益: | $184.34M |
総利益: | $109.09M (59.18 %) |
EPS: | $0.360 |
FY | 2021 |
収益: | $133.94M |
総利益: | $87.01M (64.97 %) |
EPS: | $0.660 |
Financial Reports:
No articles found.
Mesa Laboratories Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.160 (N/A) |
$0.160 (N/A) |
$0.160 (N/A) |
$0.160 (N/A) |
$0.160 (N/A) |
$0.160 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.200 | 2003-11-26 |
Last Dividend | $0.160 | 2023-11-29 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 81 | -- |
Total Paid Out | $11.06 | -- |
Avg. Dividend % Per Year | 0.19% | -- |
Score | 4.41 | -- |
Div. Sustainability Score | 7.61 | |
Div.Growth Potential Score | 5.87 | |
Div. Directional Score | 6.74 | -- |
Year | Amount | Yield |
---|---|---|
2003 | $0.200 | 3.07% |
2004 | $0.410 | 4.07% |
2005 | $0.500 | 3.85% |
2006 | $0.390 | 2.60% |
2007 | $0.340 | 1.80% |
2008 | $0.400 | 1.54% |
2009 | $0.410 | 2.27% |
2010 | $0.450 | 1.70% |
2011 | $0.490 | 1.63% |
2012 | $0.530 | 1.29% |
2013 | $0.570 | 1.08% |
2014 | $0.610 | 0.79% |
2015 | $0.640 | 0.80% |
2016 | $0.640 | 0.64% |
2017 | $0.640 | 0.52% |
2018 | $0.640 | 0.51% |
2019 | $0.640 | 0.31% |
2020 | $0.640 | 0.26% |
2021 | $0.640 | 0.23% |
2022 | $0.640 | 0.20% |
2023 | $0.640 | 0.37% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00445 | 1.500 | 9.91 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00128 | 1.200 | 9.96 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.00241 | 1.500 | -1.084 | -1.626 | [0.1 - 1] |
payoutRatioTTM | 3.63 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.68 | 0.800 | 1.606 | 1.285 | [1 - 3] |
quickRatioTTM | 1.503 | 0.800 | 5.87 | 4.69 | [0.8 - 2.5] |
cashRatioTTM | 0.639 | 1.500 | 7.56 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.318 | -1.500 | 4.70 | -7.04 | [0 - 0.6] |
interestCoverageTTM | -2.03 | 1.000 | -1.862 | -1.862 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.12 | 2.00 | 7.29 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.55 | 2.00 | 6.23 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.586 | -1.500 | 7.66 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.610 | 1.000 | 3.16 | 3.16 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0438 | 1.000 | -2.88 | -2.88 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.185 | 1.000 | -0.0812 | -0.0812 | [0.2 - 2] |
assetTurnoverTTM | 0.287 | 0.800 | -1.420 | -1.136 | [0.5 - 2] |
Total Score | 7.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 587.03 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00241 | 2.50 | -0.697 | -1.626 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.55 | 2.00 | 7.48 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.620 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.12 | 2.00 | 7.29 | 10.00 | [0 - 30] |
payoutRatioTTM | 3.63 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 1.693 | 1.500 | 2.05 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.206 | 1.000 | 7.36 | 0 | [0.1 - 0.5] |
Total Score | 5.87 |
Mesa Laboratories Inc
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。